42% of the US adult population (~110M) and almost 1 in 5 children aged 2-19 (~14M) are obese
Mounjaro vs semaglutide for type 2 diabetes: how they compare Tirzepatide (Mounjaro) and semaglutide (Ozempic, Wegovy) are both effective treatments for type 2 diabetes and, in some formulations, weight management
I ended up with travelers diarrhea, hives, tons of inflammation, bloating, and acid reflux
However, your body is primarily adjusting to the baseline dose, so immediate weight loss on the scale is rare

The most common side effects Nausea and a feeling of early satiety Vomiting Diarrhoea or constipation Abdominal pain/heavy feeling, bloating, acid reflux Loss of appetite (sometimes excessive) Contraindications and risks to be aware of Possible problems with the gallbladder or bile ducts in some people (particularly with rapid weight loss) Caution is advised in people who have had pancreatitis or who have symptoms suggestive of it (always to be assessed by a doctor) Risk of hypoglycaemia when used in combination with insulin or sulphonylureas (a dose adjustment may be necessary) Interactions with oral medicines: delayed gastric emptying may affect the absorption of certain medicines Thyroid-related issues: the PRAC/EMA concluded that the available evidence does not support a causal link between the GLP-1 receptor agonists assessed and thyroid cancer, although monitoring and appropriate use remain important Frequently asked questions What exactly is the GLP-1 hormone

Further, experimental studies, in turn, should evaluate in more controlled settings, several aspects: (i) the role of acute and chronic PE in the molecular mechanisms that are underlying the onset of the disease and thus, test whether these positive changes in mitochondria, EAS enzymes and IS modulation reflects on the epidermis and in the melanocytes from vitiligo patients